CORE LABS INC (CLB)
(Delayed Data from NYSE)
$19.31 USD
+0.41 (2.17%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $19.34 +0.03 (0.16%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.31 USD
+0.41 (2.17%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $19.34 +0.03 (0.16%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Zacks News
Core Laboratories (CLB) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of -5.26% and -0.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Schlumberger (SLB) Stock Jumps 7.7% on Uplifting Forecasts
by Zacks Equity Research
Schlumberger (SLB) expects oil activities to improve in the coming days, which in turn is likely to boost the demand for oilfield services.
Core Laboratories (CLB) Up 33.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Labs' (CLB) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
In the March quarter, Core Labs (CLB) generates $8 million in operating cash and its capital expenditure totals $2.8 million, leading to a $5.2-million free cash flow (FCF) recognition.
Core Laboratories (CLB) Q1 Earnings Top Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 15.38% and -1.61%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Labs' (CLB) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
In the December quarter, Core Labs (CLB) generates $57.9 million in operating cash and its capital expenditure totals $11.9 million, leading to a $46-million free cash flow (FCF) recognition.
Core Laboratories (CLB) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 5.88% and 3.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Core Laboratories (CLB) in Q4 Earnings?
by Zacks Equity Research
Core Laboratories' (CLB) cost-saving measures are expected to have driven fourth-quarter earnings and cash flows higher.
What's in Store for Oilfield Service in Q4 Earnings?
by Nilanjan Banerjee
Cost-cutting measures and demand recovery for oilfield equipment & services have likely aided companies belonging to the oilfield service space in Q4. SLB, BKR & CLB are yet to report earnings.
Core Labs' (CLB) Q3 Earnings Beat Estimates, Revenues Miss Mark
by Zacks Equity Research
In the September quarter, Core Labs (CLB) generates $20.7 million in operating cash and its capital expenditure totals $2.2 million, leading to $18.5-million free cash flow (FCF) recognition.
Core Laboratories (CLB) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 14.29% and -3.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Core Laboratories (CLB) in Q3 Earnings?
by Zacks Equity Research
Core Laboratories' (CLB) Production Enhancement unit is expected to have incurred operating loss in Q3, same as the previous quarter.
Factors Setting the Tone for TechnipFMC (FTI) in Q3 Earnings
by Zacks Equity Research
Softness in North American activity due to the coronavirus pandemic, which caused a crude price crash, is expected to have hurt TechnipFMC's (FTI) Surface segment's top line in Q3.
Core Laboratories (CLB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Solid Overseas Market Aid Halliburton (HAL) Q3 Earnings?
by Zacks Equity Research
Halliburton's (HAL) impressive cost-controlling measures whereby it intends to lower its 2020 capital budget to almost half at $800 million should drive the company's earnings and cash flows higher.
Oceaneering, US Navy Cut A Deal for Submarine Rescue Systems
by Zacks Equity Research
Oceaneering (OII) seals a deal with U.S. Navy to maintain and manage the Submarine Rescue Systems and provide operative and maintenance support.
Core Laboratories (CLB) Down 0.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HAL or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HAL vs. CLB: Which Stock Is the Better Value Option?
USA Compression (USAC) Incurs Wider-Than-Expected Loss in Q2
by Zacks Equity Research
USA Compression Partners' (USAC) adjusted EBITDA inches up 0.7% year over year to $105.5 million on cost-cutting initiatives.
Magellan Midstream (MMP) Q2 Earnings and Sales Lag Estimates
by Zacks Equity Research
Magellan Midstream's (MMP) distributable cash flow (DCF) of $209.5 million in the second quarter drops 33.4% from the year-ago level.
Gulfport Energy (GPOR) Down 19% Post Q2 Earnings Release
by Zacks Equity Research
In Q2, Gulfport Energy's (GPOR) total oil and gas production drops to 93,463 million cubic feet equivalent (MMcfe) from 123,668 MMcfe in the second quarter of 2019.
QEP Resources (QEP) Q2 Loss Wider Than Expected, Sales Miss
by Zacks Equity Research
QEP Resources' (QEP) total operating expenses in the second quarter decline significantly to $233.1 million from $241.7 million a year ago.
Marathon Oil (MRO) Posts Narrower-Than-Expected Loss for Q2
by Zacks Equity Research
In Q2, Marathon Oil's (MRO) average realized liquids prices (crude oil and condensate) of $21.65 per barrel fall the year-earlier level of $59.18.